Skip to content

Total Assets at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$26.48B+15.8%
Arrowhead Research logo
Arrowhead ResearchARWR
$2.27B+44.2%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$2.73B+25.8%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$903.01M+218%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.87B+8.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$1.37B+55.5%

Other financials

Income statement

See full
Revenue$31.7M+325%
Operating income-$107.2M+10.1%
Net income-$94.3M+12.9%
EPS (diluted)-$0.91+26.0%

Balance sheet

See full
Cash & equivalents$288.3M-45.4%
Total debt$250.8M+58.6%
Total equity$1.2B+3.1%

Cash flow

See full
Operating cash flow-$128.5M-23.7%
CapEx$2.2M-27.2%
Free cash flow-$130.7M-22.2%

Valuation

See full
Market cap$3.51B+24.5%
Enterprise value$3.47B+51.2%
P/S21.4×-23.0×

Profitability

See full
Operating margin-226.6%-90.5pp
Net margin-742.7%
FCF margin-234%-86.6pp

Returns & leverage

See full
Return on equity-47.1%
Debt / equity0.2×+0.1×
Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Beam Therapeutics's total assets?
Beam Therapeutics (BEAM) reported total assets of $1.48B in Q1 2026.
How has Beam Therapeutics's total assets changed year-over-year?
Beam Therapeutics's total assets increased by 0.9% year-over-year, from $1.47B to $1.48B.
What is the long-term trend for Beam Therapeutics's total assets?
Over 5 years (2020 to 2025), Beam Therapeutics's total assets has grown at a 26.8% compound annual growth rate (CAGR), from $451.68M to $1.48B.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.